96 related articles for article (PubMed ID: 2741899)
1. Diabetic gastroparesis in a patient with Parkinson's disease: effective treatment with domperidone.
Day JP; Pruitt RE
Am J Gastroenterol; 1989 Jul; 84(7):837-8. PubMed ID: 2741899
[No Abstract] [Full Text] [Related]
2. [Diabetic gastroparesis treated with domperidone].
Maréchaud R; Abadie JC; Quéron B; Ziegler JE; Sudre Y
Nouv Presse Med; 1982 Nov; 11(44):3273-4. PubMed ID: 7155830
[No Abstract] [Full Text] [Related]
3. Treatment of diabetic gastroparesis with oral domperidone.
Watts GF; Armitage M; Sinclair J; Hill RD
Diabet Med; 1985 Nov; 2(6):491-2. PubMed ID: 2951124
[TBL] [Abstract][Full Text] [Related]
4. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment.
Koch KL; Stern RM; Stewart WR; Vasey MW
Am J Gastroenterol; 1989 Sep; 84(9):1069-75. PubMed ID: 2773901
[TBL] [Abstract][Full Text] [Related]
5. Diabetic gastroparesis and colonic dilatation treated with domperidone.
Heer M; Pirovino M; Japp H; Buhler H; Schmid M
Lancet; 1980 Nov; 2(8204):1145-6. PubMed ID: 6107763
[No Abstract] [Full Text] [Related]
6. Gastroparesis diabeticorum.
Kravetz RE
Ariz Med; 1966 Jun; 23(6):439-42. PubMed ID: 5938586
[No Abstract] [Full Text] [Related]
7. Domperidone, a new dopamine antagonist.
Champion MC; Hartnett M; Yen M
CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Soykan I; Sarosiek I; Shifflett J; Wooten GF; McCallum RW
Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
[TBL] [Abstract][Full Text] [Related]
9. Gastroparesis diabeticorum.
Cho SR; Turner MA; Henry DA
J Can Assoc Radiol; 1983 Mar; 34(1):32-5. PubMed ID: 6841418
[TBL] [Abstract][Full Text] [Related]
10. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
11. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.
Schoffer KL; Henderson RD; O'Maley K; O'Sullivan JD
Mov Disord; 2007 Aug; 22(11):1543-9. PubMed ID: 17557339
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis.
Longstreth GF; Malagelada JR; Kelly KA
Ann Intern Med; 1977 Feb; 86(2):195-6. PubMed ID: 835945
[No Abstract] [Full Text] [Related]
13. [Gastric emptying disorders in diabetic gastroparesis].
Vogelberg KH
Dtsch Med Wochenschr; 1988 Jun; 113(24):988-91. PubMed ID: 3288466
[No Abstract] [Full Text] [Related]
14. [Disorders of gastric emptying in diabetes. II. Treatment].
Czambor-Ksiazek E; Pokrzywnicki W; Grzeszczak W; Duda G
Wiad Lek; 1997; 50(1-3):39-41. PubMed ID: 9297356
[TBL] [Abstract][Full Text] [Related]
15. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
Dumitrascu DL; Weinbeck M
Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
[No Abstract] [Full Text] [Related]
16. [Amyloidosis with gastroparesis. Improvement with domperidone].
Gil R; Debiais F; Lefevre JP; Pouget-Abadie JF; Marechaud R; Simmat G; Boissonnot L
Presse Med; 1984 Mar; 13(9):564. PubMed ID: 6230656
[No Abstract] [Full Text] [Related]
17. [The gastroparesis of diabetics].
Larcan A; Huriet C; Charles JM
Diabete; 1966 Jan; 14(1):13-9. PubMed ID: 5905792
[No Abstract] [Full Text] [Related]
18. A case of antral tachygastria: symptomatic and myoelectric improvement with gastroenterostomy and domperidone therapy.
Reynolds RP; Bardakjian BL; Diamant NE
Can Med Assoc J; 1983 Apr; 128(7):826-9. PubMed ID: 6831324
[No Abstract] [Full Text] [Related]
19. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
20. [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
Chamontin B; Montastruc JL; Rascol A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1181-5. PubMed ID: 6151826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
